As GLP-1 drugs transition from diabetes treatment to widespread weight management tools, experts question the safety of prolonged use and highlight barriers due to high costs and unregulated alternatives, prompting calls for sustained medical oversight. GLP-1 medicines have moved rapidly…
As GLP-1 medications become a common treatment for weight loss and diabetes, experts highlight promising benefits but warn of unresolved safety concerns, especially around long-term use and discontinuation risks amid rising costs and access challenges. GLP-1 medicines are moving from…
The Blueberry GLP supplement’s fluctuating ingredient claims and lack of clinical evidence underscore growing fears about the credibility of over-the-counter GLP-1 products, which often misrepresent their medical potential. Blueberry GLP is marketed as a natural answer to blood sugar control,…
A recent response to critiques highlights ongoing efforts to validate the systemic inflammatory response index (SIRI) as an accessible tool for assessing severe diabetic foot infections, amid calls for more robust prospective evidence and refinement. A response published by Dovepress…
A dietitian at Sivas Numune Hospital stresses the importance of controlling sugar intake as Turkey observes World Sugar Awareness Week, urging consumers to read labels and opt for healthier alternatives to reduce risks linked to excessive sugar consumption. During World…
Zucara Therapeutics’ ZT-01 shows promise in phase 1 trials by enhancing glucagon response during hypoglycaemia, potentially offering a new approach to managing low blood sugar episodes in type 1 diabetics without increasing overall glucose levels. Type 1 diabetes carries a…
A Taiwanese doctor highlights how traditional Mid-Autumn Festival celebrations featuring high-sugar foods like mooncakes could be early indicators of serious health problems such as diabetes and cardiovascular disease, urging men to monitor their sexual health and lifestyle habits. As the…
Emerging evidence suggests brief, daily movement bursts, known as exercise snacks, offer a practical and effective way to improve metabolic, cardiovascular, and brain health, making exercise more accessible for busy individuals and those with health conditions like diabetes. A growing…
A new study indicates that discontinuing GLP-1 receptor agonists can diminish their heart-protective effects, highlighting the importance of ongoing treatment for patients with type 2 diabetes. A large study from Washington University School of Medicine in St. Louis has found…
A new review highlights promising results for platelet-rich plasma as an adjunct therapy for diabetic foot ulcers, yet underscores the need for standardised research to confirm its long-term safety and efficacy. Platelet-rich plasma is emerging as a possible add-on treatment…
